Pełna treść
Chronic Hand Eczema – Unmet Needs and New Therapeutic Approach with Topical JAK Inhibitor Delgocitinib
Department of Dermatology, Centre of Postgraduate Medical Education, Warsaw, Poland
Dermatology Clinic National Institute of Medicine of the Ministry of Interior and Administration, Warsaw, Poland
Department of Dermatology, Military Institute of Medicine – National Research Institute, Warsaw, Poland
Department of Dermatology, Faculty of Medicine, Collegium Medicum, Jan Kochanowski University, Kielce, Poland
Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, Poland
Department of Dermatology, Venereology and Allergology, University Clinical Center, Gdansk, Poland
Division of Dermatology, Venereology and Clinical Immunology, Faculty of Medicine, Wroclaw University of Science and Technology, Wroclaw, Poland
Department of Dermato-Venereology, 4th Military Hospital, Wroclaw, Poland
Department of Dermatology, Pediatric Dermatology and Oncology, Medical University of Lodz, Poland
Laboratory of Autoinflammatory, Genetic and Rare Skin Disorders, Medical University of Lodz, Poland
Department of Dermatology, Faculty of Medicine, University of Rzeszow, Poland
Dermatol Rev/Przegl Dermatol 2026, 113, 204–218
- Mense S.A. Maher S., Chovatiya R.A.: Practical approach to chronic hand eczema. Dermatol Ther (Heidelb) 2025, 15, 1953-1971.
- Weidinger S., Novak N.: Hand eczema. Lancet 2024, 404, 2476-2486.
- Weisshaar E. Chronic hand eczema. Am J Clin Dermatol 2024, 25, 909-926.
- Christoffers W.A., Coenraads P.J., Svensson Å., Diepgen T.L., Dickinson-Blok J.L., Xia J., et al.: Interventions for hand eczema. Cochrane Database Syst Rev 2019, 4, Cd004055.
- Giménez-Arnau A., Bewley A., Apfelbacher C., Fargnoli M.C., Rault B., Morillo A., et al.: Physician-reported treatment patterns in moderate to severe chronic hand eczema: the RWEAL multinational medical chart review. Dermatol Ther 2025, 15, 3577-3592.
- Thyssen J.P., Schuttelaar M.L.A., Alfonso J.H., Andersen K.E., Angelova-Fischer I., Arents B.W.M., et al.: Guidelines for diagnosis, prevention, and treatment of hand eczema. Contact Dermatitis 2022, 86, 357-378.
- Apfelbacher C., Bewley A., Molin S., Fargnoli M.C., Giménez-Arnau A.M., Brignoli L., et al.: Prevalence of chronic hand eczema in adults: a cross-sectional survey of over 60 000 respondents from the general population of Canada, France, Germany, Italy, Spain and the UK. Br J Dermatol 2025, 192, 1047-1054.
- Yüksel Y.T., Thyssen J.P., Nørreslet L.B., Flachs E.M., Ebbehøj N.E., Agner T.A.: Comparison between self-reported hand eczema and self-reported signs and symptoms of skin lesions indicating hand eczema. Contact Dermatitis 2022, 87, 528-534.
- Vestergaard L., Clemmensen O.J., Sørensen F.B., Andersen K.E.: Histological distinction between early allergic and irritant patch test reactions: follicular spongiosis may be characteristic of early allergic contact dermatitis. Contact Dermatitis 1999, 41, 207-210.
- Frings V.G., Böer-Auer A., Breuer K.: Histomorphology and immunophenotype of eczematous skin lesions revisited – skin biopsies are not reliable in differentiating allergic contact dermatitis, irritant contact dermatitis, and atopic dermatitis. Am J Dermatopathol 2018, 40, 7-16.
- Agner T., Aalto-Korte K., Andersen K.E., Foti C., Gimenéz-Arnau A., Goncalo M., et al.: Classification of hand eczema. J Eur Acad Dermatol Venereol 2015, 29, 2417-2422.
- Bissonnette R., Agner T., Molin S., Guttman-Yassky E.: Hand eczema – Part 1: epidemiology, pathogenesis, diagnosis, and work-up. J Am Acad Dermatol 2025, 93, 1201-1210.
- Johansen J.D., Hald M., Andersen B.L., Laurberg G., Danielsen A., Avnstorp C., et al.: Classification of hand eczema: clinical and aetiological types. Based on the guideline of the Danish Contact Dermatitis Group. Contact Dermatitis 2011, 65, 13-21.
- Ghezzi G., Falcidia C., Paolino G., Mercuri S.R., Narcisi A., Costanzo A., et al.: Chronic hand eczema (CHE): a narrative review. Dermatol Ther (Heidelb) 2025, 15, 771-795.
- Agarwal U.S., Besarwal R.K., Gupta R., Agarwal P., Napalia S.: Hand eczema. Indian J Dermatol 2014, 59, 213-224.
- Ong P.Y., Leung D.Y.M.: Bacterial and viral infections in atopic dermatitis: a comprehensive review. Clin Rev Allergy Immunol 2016, 51, 329-337.
- Nemeth V., Syed H., Evans J.: Eczema. StatPearls. 2025.
- Johansen J.D., Aalto-Korte K., Agner T., Andersen K.E., Bircher A., Bruze M., et al.: European Society of Contact Dermatitis guideline for diagnostic patch testing – recommendations on best practice. Contact Dermatitis 2015, 73, 195-221.
- Bauer A., Brans R., Brehler R., Büttner M., Dickel H., Elsner P., et al.: S2k guideline diagnosis, prevention, and therapy of hand eczema. J Dtsch Dermatol Ges 2023, 21, 1054-1074.
- International Statistical Classification of Diseases and Related Health Problems 10th Revision, Sixth edition, 2019. Available online (accessed on 2 Feb 2026).
- Lobefaro F., Gualdi G., Di Nuzzo S., Amerio P.: Atopic dermatitis: clinical aspects and unmet needs. Biomedicines 2022, 10, 2927.
- Molin S.: Pathogenese des Handekzems. Der Hautarzt 2019, 70, 755-759.
- Jamil W., Svensson Å., Josefson A., Lindberg M., von Kobyletzki L.: Incidence rate of hand eczema in different occupations: a systematic review and meta-analysis. Acta Dermatovenereol 2022, 102, adv00681.
- Lee G.R., Maarouf M., Hendricks A.K., Lee D.E., Shi V.Y.: Current and emerging therapies for hand eczema. Dermatol Ther 2019, 32, e12840.
- Patel D., Belsito D.V.: The detection of clinically relevant contact allergens with a standard screening tray of 28 allergens. Contact Dermatitis 2012, 66, 154-158.
- Giménez-Arnau A.M., Pesqué D., Maibach H.I.: Contact urticaria syndrome: a comprehensive review. Curr Dermatol Rep 2022, 11, 194-201.
- Levin C., Warshaw E.: Protein contact dermatitis: allergens, pathogenesis, and management. Dermatitis 2008, 19, 241-251.
- Barbaud A., Poreaux C., Penven E., Waton J.: Occupational protein contact dermatitis. Eur J Dermatol 2015, 25, 527-534.
- Barbaud A.: Mechanism and diagnosis of protein contact dermatitis. Curr Opin Allergy Clin Immunol 2020, 20, 117-121.
- Karagounis T.K., Cohen D.E.: Occupational hand dermatitis. Curr Allergy Asthma Rep 2023, 23, 201-212.
- Voorberg A.N., Loman L., Schuttelaar M.L.A.: Prevalence and severity of hand eczema in the Dutch general population: a cross-sectional, questionnaire study within the Lifelines cohort study. Acta Derm Venereol 2022, 102, adv00626.
- Thyssen J.P., Johansen J.D., Linneberg A., Menné T.: The epidemiology of hand eczema in the general population--prevalence and main findings. Contact Dermatitis 2010, 62, 75-87.
- Quaade A.S., Simonsen A.B., Halling A.S., Thyssen J.P., Johansen J.D.: Prevalence, incidence, and severity of hand eczema in the general population – a systematic review and meta-analysis. Contact Dermatitis 2021, 84, 361-374.
- Hald M., Berg N.D., Elberling J., Johansen J.D.: Medical consultations in relation to severity of hand eczema in the general population. Br J Dermatol 2008, 158, 773-777.
- Brands M.J., Loman L., Schuttelaar M.L.A.: Exposure and work-related factors in subjects with hand eczema: data from a cross-sectional questionnaire within the Lifelines Cohort Study. Contact Dermatitis 2022, 86, 493-506.
- Polecka A., Awchimkow A., Owsianko N., Baran A., Hermanowicz J.M., Flisiak I.: Hand eczema in the Polish female population. J Clin Med 2023, 12, 6102.
- Silvestre Salvador J.F., Heras Mendaza F., Hervella Garcés M., Palacios-Martínez D., Sánchez Camacho R., Senan Sanz R., et al.: Guidelines for the diagnosis, treatment, and prevention of hand eczema. Actas Dermosifiliogr 2020, 111, 26-40.
- Meding B., Lindahl G., Alderling M., Wrangsjö K., Anveden Berglind I.: Is skin exposure to water mainly occupational or nonoccupational? A population-based study. Br J Dermatol 2013, 168, 1281-1286.
- Uter W., Johansen J.D., Macan J., Symanzik C., John S.M.: Diagnostics and prevention of occupational allergy in hairdressers. Curr Allergy Asthma Rep 2023, 23, 267-275.
- Japundžić I., Bembić M., Špiljak B., Parać E., Macan J., Lugović-Mihić L.: Work-related hand eczema in healthcare workers: etiopathogenic factors, clinical features, and skin care. Cosmetics 2023, 10, 134.
- Sedeh F.B., Michaelsdóttir T.E., Jemec G.B.E., Mortensen O.S., Ibler K.S.: Prevalence, risk factors, and prevention of occupational contact dermatitis among professional cleaners: a systematic review. Int Arch Occup Environ Health 2023, 96, 345-354.
- Schnuch A.: Hand eczema in young people: atopic dermatitis and beyond. Br J Dermatol 2021, 185, 17-18.
- Haft M.A., Park H.H., Lee S.S., Sprague J.M., Eichenfield L.F.: Pediatric chronic hand eczema: epidemiology, clinical presentation, and management. JAAD Int 2023, 11, 165-173.
- Haft M.A., Park H.H., Lee S.S., Sprague J.M., Paller A.S., Cotton C.H., et al.: Diagnosis and management of pediatric chronic hand eczema: the PeDRA CACHES survey. Pediatric Drugs 2023, 25, 459-466.
- Zalewski A., Krajewski P.K., Szepietowski J.C.: Prevalence and characteristics of itch and pain in patients suffering from chronic hand eczema. J Clin Med 2023, 12, 4198.
- de León F.J., Berbegal L., Silvestre J.F.: Management of chronic hand eczema. Actas Dermosifiliogr 2015, 106, 533-544.
- Elsner P., Agner T.: Hand eczema: a ‘neglected’ disease. J Eur Acad Dermatol Venereol 2020, 34 Suppl 1, 3.
- Kouris A., Armyra K., Christodoulou C., Katoulis A., Potouridou I., Tsatovidou R., et al.: Quality of life, anxiety, depression and obsessive-compulsive tendencies in patients with chronic hand eczema. Contact Dermatitis 2015, 72, 367-370.
- Agner T., Andersen K.E., Brandao F.M., Bruynzeel D.P., Bruze M., Frosch P., et al.: Hand eczema severity and quality of life: a cross-sectional, multicentre study of hand eczema patients. Contact Dermatitis 2008, 59, 43-47.
- Buhl T., Bauer A., Ehst B.D., Thyssen J.P., Hahn-Pedersen J., Hagen B.F., et al.:. Health-related quality of life in chronic hand eczema in a Phase 2b trial of delgocitinib cream. Dermatol Ther (Heidelb) 2025, 15, 1181-1193.
- Zalewski A., Krajewski P.K., Szepietowski J.C.: Psychosocial consequences of hand eczema – a prospective cross-sectional study. J Clin Med 2023, 12, 5741.
- Armstrong A., Hahn-Pedersen J., Bartlett C., Glanville J., Thyssen J.P.: Economic burden of chronic hand eczema: a review. Am J Clin Dermatol 2022, 23, 287-300.
- Cvetkovski R.S., Rothman K.J., Olsen J., Mathiesen B., Iversen L., Johansen J.D., et al.:. Relation between diagnoses on severity, sick leave and loss of job among patients with occupational hand eczema. Br J Dermatol 2005, 152, 93-98.
- Böhm, D., Stock Gissendanner S., Finkeldey F., John S.M., Werfel T., Diepgen T.L., et al.: Severe occupational hand eczema, job stress and cumulative sickness absence. Occup Med 2014, 64, 509-515.
- Capucci S., Hahn-Pedersen J., Vilsbøll A., Kragh N.: Impact of atopic dermatitis and chronic hand eczema on quality of life compared with other chronic diseases. Dermatitis 2020, 31, 178-184.
- Gisondi P., Puig L., Richard M.A., Paul C., Nijsten T., Taieb C., et al.: Quality of life and stigmatization in people with skin diseases in Europe: A large survey from the ‘burden of skin diseases’ EADV project. J Eur Acad Dermatol Venereol 2023, 37 Suppl 7, 6-14.
- Daudén E., Belinchón I., Colominas-González E., Coto P., de la Cueva P., Gallardo F., et al.: Defining well-being in psoriasis: a Delphi consensus among healthcare professionals and patients. Sci Rep 2024, 14, 14519.
- Yu M., Han T.Y., Lee J.H., Son S.J.: The quality of life and depressive mood among Korean patients with hand eczema. Ann Dermatol 2012, 24, 430-437.
- Agrawal S., Rijal A., Bhattarai S.: Impact of patch testing on quality of life in patients with hand eczema: a follow-up study. Kathmandu Univ Med J 2013, 11, 216-220.
- Mossing K., Dizdarevic A., Svensson Å., Sonesson A.: Impact on quality of life of an intervention providing additional information to patients with allergic contact dermatitis; a randomized clinical trial. J Eur Acad Dermatol Venereol 2022, 36, 2166-2171.
- Sloot M.M., Loman L., Romeijn G.L.E., Rosenberg F.M., Arents B.W.M., Schuttelaar M.L.A.: Patients’ perspectives on quality of care for chronic hand eczema: a qualitative study. Contact Dermatitis 2022, 86, 204-212.
- Cunha A.S., Vitorino G., Silva J.M.E., Coelho P.S.: Economic burden of atopic dermatitis in Portugal: a cross-sectional study. Sci Rep 2025, 15, 7717.
- Grant L., Seiding Larsen L., Burrows K., Belsito D.V., Weisshaar E., Diepgen T., et al:. Development of a conceptual model of chronic hand eczema (CHE) based on qualitative interviews with patients and expert dermatologists. Adv Ther 2020, 37, 692-706.
- Diepgen T.L., Purwins S., Posthumus J., Kuessner D., John S.M., Augustin M.: Cost-of-illness analysis of patients with chronic hand eczema in routine care in Germany: focus on the impact of occupational disease. Acta Derm Venereol 2013, 93, 538-543.
- Politiek K., Oosterhaven J.A.F., Vermeulen K.M., Schuttelaar M.L.A.: Systematic review of cost-of-illness studies in hand eczema. Contact Dermatitis 2016, 75, 67-76.
- Rothstein B.E., Gonzalez J., Cunningham K., Saraiya A., Dornelles A.C., Nguyen B.M.: Direct and indirect patient costs of dermatology clinic visits and their impact on access to care and provider preference. Cutis 2017, 100, 405-410.
- Manjelievskaia J., Boytsov N., Brouillette M.A., Onyekwere U., Pierce E., Goldblum O., et al.: The direct and indirect costs of adult atopic dermatitis. J Manag Care Spec Pharm 2021, 27, 1416-1425.
- Beretzky Z., Koszorú K., Rencz F., Hajdu K., Borza J., Bodai K., et al.: Societal costs and health related quality of life in adult atopic dermatitis. BMC Health Serv Res 2023, 23, 859.
- Elsner P., Agner T.: Hand eczema: treatment. J Eur Acad Dermatol Venereol 2020, 34 Suppl 1, 13-21.
- Dubin C., Del Duca E., Guttman-Yassky E.: Drugs for the treatment of chronic hand eczema: successes and key challenges. Ther Clin Risk Manag 2020, 16, 1319-1332.
- Ho J.S.S., Molin S.: A review of existing and new treatments for the management of hand eczema. J Cutan Med Surg 2023, 27, 493-503.
- Egeberg A., Schlapbach C., Haugaard J.H., Nymand L., Thein D., Thomsen S.F., et al.: Adverse events from topical corticosteroid use in chronic hand eczema – findings from the Danish Skin Cohort. JAAD Int 2024, 14, 77-83.
- Ference J.D., Last A.R.: Choosing topical corticosteroids. Am Fam Physician 2009, 79, 135-140.
- Saraswat A.: Contact allergy to topical corticosteroids and sunscreens. Indian J Dermatol Venereol Leprol 2012, 78, 552-559.
- Diepgen T.L., Andersen K.E., Chosidow O., Coenraads P.J., Elsner P., English J., et al.: Guidelines for diagnosis, prevention and treatment of hand eczema. J Dtsch Dermatol Ges 2015, 13, e1-22.
- Yu S.H., Drucker A.M., Lebwohl M., Silverberg J.I.: A systematic review of the safety and efficacy of systemic corticosteroids in atopic dermatitis. J Am Acad Dermatol 2018, 78, 733-740.e711.
- Politiek K., Christoffers W.A., Coenraads P.J., Schuttelaar M.A.: Alitretinoin and acitretin in severe chronic hand eczema; results from a retrospective daily practice study. Dermatol Ther 2016, 29, 364-371.
- Acitretin (Neotigason) 25 mg Capsules: Summary of Product Characteristics (SmPC). Available online (accessed on 10 Feb 2026).
- Agency E.M.: Retinoids containing medicinal products (Article 31 referral): Annex III. Amendments to relevant sections of the product information., European Medicines Agency: https://www.ema.europa.eu/en/documents/referral/retinoid-article-31-referral-annex-iii_en.pdf, 2018.
- Reinold J., Kollhorst B., Temme H.L., Wentzell N., Haug U.: Use of acitretin among girls and women of childbearing age and occurrence of acitretin-exposed pregnancies in Germany. Clin Drug Investig 2023, 43, 865-872.
- Kislat A., Olah P., Kuchner M., Gerber P.A., Schrader J., Meller S., et al.:. The endogenous dual retinoid receptor agonist alitretinoin exhibits immunoregulatory functions on antigen-presenting cells. Int J Mol Sci 2023, 24, 9654.
- Garnock-Jones K.P., Perry C.M.: Alitretinoin: in severe chronic hand eczema. Drugs 2009, 69, 1625-1634.
- Rekomendacja nr 67/2018 (Toctino – alitretynoina). 2018.
- Ruzicka T., Lynde C.W., Jemec G.B., Diepgen T., Berth-Jones J., Coenraads P.J., et al.: Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol 2008, 158, 808-817.
- Ruzicka T., Larsen F.G., Galewicz D., Horváth A., Coenraads P.J., Thestrup-Pedersen K., et al.: Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial. Arch Dermatol 2004, 140, 1453-1459.
- van Coevorden A.M., Kamphof W.G., van Sonderen E., Bruynzeel D.P., Coenraads P.J.: Comparison of oral psoralen-UV-A with a portable tanning unit at home vs hospital-administered bath psoralen-UV-A in patients with chronic hand eczema: an open-label randomized controlled trial of efficacy. Arch Dermatol 2004, 140, 1463-1466.
- Archier E., Devaux S., Castela E., Gallini A., Aubin F., Le Maître M., et al.: Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 2012, 26 Suppl 3, 22-31.
- Lodén M., Wirén K., Smerud K., Meland N., Hønnås H., Mørk G., et al.: Treatment with a barrier-strengthening moisturizer prevents relapse of hand-eczema. An open, randomized, prospective, parallel group study. Acta Derm Venereol 2010, 90, 602-606.
- Bauer A., Rönsch H., Elsner P., Dittmar D., Bennett C., Schuttelaar M.L.A., et al.: Interventions for preventing occupational irritant hand dermatitis. Cochrane Database Syst Rev 2018, 4, Cd004414.
- Kütting B., Baumeister T., Weistenhöfer W., Pfahlberg A., Uter W., Drexler H.: Effectiveness of skin protection measures in prevention of occupational hand eczema: results of a prospective randomized controlled trial over a follow-up period of 1 year. Br J Dermatol 2010, 162, 362-370.
- Kampf G., Löffler H.: Prevention of irritant contact dermatitis among health care workers by using evidence-based hand hygiene practices: a review. Ind Health 2007, 45, 645-652.
- Borg E., Munro D., Thoning H.: The management of chronic hand eczema: a retrospective patient record review. Contact Dermatitis 2024, 90, 365-371.
- Oosterhaven J.A., Politiek K., Schuttelaar M.A.: Azathioprine treatment and drug survival in patients with chronic hand eczema – results from daily practice. Contact Dermatitis 2017, 76, 304-307.
- Politiek K., van der Schaft J., Christoffers W.A., Coenraads P.J., van den Reek J.M., de Jong E.M., et al.: Drug survival of methotrexate treatment in hand eczema patients: results from a retrospective daily practice study. J Eur Acad Dermatol Venereol 2016, 30, 1405-1407.
- Wollenberg A., Kinberger M., Arents B., Aszodi N., Barbarot S., Bieber T., et al.: European Guideline (EuroGuiDerm) on atopic eczema: living update. J Eur Acad Dermatol Venereol 2025, 39, 1537-1566.
- NICE. Delgocitinib for treating moderate to severe chronic hand eczema. London: National Institute for Health and Care Excellence (NICE); 2025 Nov 5. (National Institute for Health and Care Excellence: Technology Appraisals, No. TA1107.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK619969/.
- Tancredi V., Buononato D., Caccavale S., Di Brizzi E.V., Di Caprio R., Argenziano G., et al.: New perspectives in the management of chronic hand eczema: lessons from pathogenesis. Int J Mol Sci 2024, 25, 362.
- Jimenez P.A., Sofen H.L., Bissonnette R., Lee M., Fowler J., Zammit D.J., et al.: Oral spleen tyrosine kinase/Janus Kinase inhibitor gusacitinib for the treatment of chronic hand eczema: results of a randomized phase 2 study. J Am Acad Dermatol 2023, 89, 235-242.
- Nakagawa H., Nemoto O., Igarashi A., Saeki H., Kaino H., Nagata T.: Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: a phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study. J Am Acad Dermatol 2020, 82, 823-831.
- Association NE. FDA Accepts LEO Pharma’s Filing of Delgocitinib Cream New Drug Application for the Treatment of Chronic Hand Eczema. Available online (accessed on 10 Feb 2026).
- Agency E.M.: Anzupgo. European public assessment report (EPAR) page for Anzupgo., EMA/372390/2024; European Medicines Agency: https://www.ema.europa.eu/en/documents/assessment-report/anzupgo-epar-public-assessment-report_en.pdf, 2024-09-24 2024.
- Summary of Product Characteristics. Anzupgo, INN-delgocitinib; https://www.ema.europa.eu/pl/documents/product-information/anzupgo-epar-product-information_pl.pdf.
- Schliemann S., Pinter A., Schuttelaar M.L.A.: Efficacy and safety of delgocitinib cream in adults with moderate-to-severe chronic hand eczema: results of the Phase 3 DELTA 1 trial. In Proceedings of the 32 European academy of dermatology and venereology (EADV) congress, Berlin, 2023.
- Bissonnette R., Warren R.B., Pinter A., Agner T., Gooderham M., Schuttelaar M.L.A., et al.: Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials. Lancet 2024, 404, 461-473.
- Gooderham M., Molin S., Bissonnette R., Worm M., Crépy M.N., Stingeni L., et al.: Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with chronic hand eczema: results of the phase 3 open-label extension DELTA 3 trial following the DELTA 1 and 2 trials. J Am Acad Dermatol 2025, 93, 95-103.
- Haider E., Tanveer L., Usman Iqbal M., Taj J., Tague C.: Delgocitinib in dermatology: a topical pan-JAK inhibitor for chronic hand eczema and atopic dermatitis. Ann Med Surg 2025, 87, 7928-7929.
- Bauer A., Schuttelaar M.L., Baranowski K., Plohberger U., Sørensen L., Worm M.: Delgocitinib cream reduces itch and pain in moderate to severe chronic hand eczema: phase 3 DELTA 1 and 2 pooled analyses. Dermatol Ther 2026, 16, 1241-1253.
- Giménez-Arnau A.M., Pinter A., Sondermann W., Reguiai Z., Woolf R., Lynde C., et al.: Efficacy and safety of topical delgocitinib cream versus oral alitretinoin capsules in adults with severe chronic hand eczema (DELTA FORCE): a 24-week, randomised, head-to-head, phase 3 trial. Lancet 2025, 405, 1676-1688.
- Basra M.K.A., Salek M.S., Camilleri L., Sturkey R., Finlay A.Y.: Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data. Dermatology 2015, 230, 27-33.
- Delgocitinib for treating moderate to severe chronic hand eczema. Technology appraisal guidance. Available online (accessed on 10 Feb 2026).
- Anzupgo. Available online (accessed on 10 Feb 2026).
- Issa N.T., Yu J., Bunick C.G., Kircik L.: The utility of delgocitinib in chronic hand eczema. J Drugs Dermatol 2025, 24, 25412.
- Cohen D., Bewley A., Wollenberg A., Hong H.C., Armstrong A., Jonsen E., et al.: Matching-adjusted indirect comparison of the efficacy of delgocitinib cream and dupilumab in the treatment of moderate to severe atopic hand eczema. Dermatol Ther 2026, 16, 423-436.

